Prostate carcinoma bone-stroma interaction and its biologic and therapeutic implications (Q35053933)

6 August 2017

1 reference

title

Prostate carcinoma bone-stroma interaction and its biologic and therapeutic implications (English)

1 reference

6 August 2017

1 reference

Leland W K Chung

1

1 reference

PubMed ID

12548574

6 August 2017

language of work or name

English

0 references

publication date

1 February 2003

1 reference

6 August 2017

7

1 reference

inferred from page(s)

published in

Cancer

1 reference

6 August 2017

97

1 reference

6 August 2017

3 Suppl

1 reference

6 August 2017

772-778

1 reference

Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial

6 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Metastatic prostate carcinoma to bone: clinical and pathologic features associated with cancer-specific survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

A comparative study of the ultrastructure and lack of growth capacity of adult human prostate epithelium mechanically separated from its stroma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Stromal-epithelial interactions: II. Regulation of prostatic growth by embryonic urogenital sinus mesenchyme

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Tissue Interactions and Prostatic Growth. I. Induction of Adult Mouse Prostatic Hyperplasia by Fetal Urogenital Sinus Implants 1

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Tissue interactions and prostatic growth: II. Morphological and biochemical characterization of adult mouse prostatic hyperplasia induced by fetal urogenital sinus implants

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Co-inoculation of tumorigenic rat prostate mesenchymal cells with non-tumorigenic epithelial cells results in the development of carcinosarcoma in syngeneic and athymic animals

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Fibroblast-mediated acceleration of human epithelial tumor growth in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Prostate and bone fibroblasts induce human prostate cancer growth in vivo: implications for bidirectional tumor-stromal cell interaction in prostate carcinoma growth and metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Growth factors and epithelial-stromal interactions in prostate cancer development

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Permanent phenotypic and genotypic changes of prostate cancer cells cultured in a three-dimensional rotating-wall vessel

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Can cancer cells transform normal host cells into malignant cells?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Prostate epithelial differentiation is dictated by its surrounding stroma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

What might a stromal response mean to prostate cancer progression?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Adaptive mutations in Escherichia coli as a model for the multiple mutational origins of tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Androgen-repressed phenotype in human prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Regulation of human osteocalcin promoter in hormone-independent human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Mechanisms governing bone metastasis in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Metastatic bone disease: clinical features, pathophysiology and treatment strategies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Molecular mechanisms of osteolytic bone metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Superoxide and bone resorption

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Upregulation of vascular endothelial growth factor by hydrogen peroxide in human colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Reactive oxygen generated by Nox1 triggers the angiogenic switch

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Upregulation of endothelin 1 and its precursor by IL-1beta, TNF-alpha, and TGF-beta in the PC3 human prostate cancer cell line

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Endothelin-1 production by prostate cancer cell lines is up-regulated by factors involved in cancer progression and down-regulated by androgens

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

The distribution of secondary growths in cancer of the breast. 1889

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

The role of alpha(v)beta(3) in prostate cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

The functional and clinical roles of osteopontin in cancer and metastasis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Expression of insulin-like growth factor-1 receptor in human colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Molecular basis of co-targeting prostate tumor and stroma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Substrate specificity of alpha(v)beta(3) integrin-mediated cell migration and phosphatidylinositol 3-kinase/AKT pathway activation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11140

7 January 2021

Identifiers

DOI

10.1002/CNCR.11140

1 reference

6 August 2017

1 reference

PubMed ID

12548574